¥61 million impairment loss on investment securities recorded
First written in FY2019-Q3. 3 of 19 entries say "Restated". Latest entry: FY2025.
11 other companies' latest entry also says "Other".
- FY2025¥10 million valuation loss on securities recordedAnnual report
「Valuation loss on securities 10」
A ¥10 million valuation loss on securities was recorded as a non-operating expense in the current consolidated fiscal year. - FY2025-H1¥18 million valuation loss on securities recordedAnnual report
「Valuation loss on securities - 18」
A valuation loss on securities of ¥18 million was recorded in the current interim consolidated accounting period, whereas no such loss was recorded in the same period of the previous year. - FY2024-Q3RestatedAnnual report
「Impairment loss on investment securities - 110」
The impairment loss on investment securities was ¥110 million in the nine-month period of the current consolidated fiscal year, unchanged from the six-month period. - FY2024-Q2¥110 million impairment loss on investment securities recordedAnnual report
「Impairment loss on investment securities - 110」
An impairment loss on investment securities of ¥110 million was recorded in the six-month period of the current consolidated fiscal year, contributing to a decrease in quarterly net income attributable to owners of the parent. - FY2024-Q1¥81 million impairment loss on investment securities recordedAnnual report
「Impairment loss on investment securities - 81」
An impairment loss on investment securities of ¥81 million was recorded in the three-month period of the current consolidated fiscal year, whereas no such loss was recorded in the same period of the previous year. - FY2023-Q3RestatedAnnual report
「Impairment loss on investment securities 12 —」
No impairment loss on investment securities was recorded in the nine-month period of the current consolidated fiscal year, a decrease from ¥12 million in the same period of the previous year. - FY2023-Q2No impairment loss on investment securities recognizedAnnual report
「Impairment loss on investment securities 8 -」
No impairment loss on investment securities was recorded in the six-month period of the current consolidated fiscal year, a decrease from ¥8 million in the same period of the previous year. - FY2022-Q3¥12 million impairment loss on investment securities recordedAnnual report
「Impairment loss on investment securities — 12」
An impairment loss on investment securities of ¥12 million was recorded in the nine-month period of the current consolidated fiscal year, whereas no such loss was recorded in the same period of the previous year. - FY2022-Q2¥8 million impairment loss on investment securities recordedAnnual report
「Impairment loss on investment securities — 8」
An impairment loss on investment securities of ¥8 million was recorded in the six-month period of the current consolidated fiscal year, whereas no such loss was recorded in the same period of the previous year. - FY2022-Q1¥21 million impairment loss on investment securities recordedAnnual report
「Loss on valuation of investment securities - 21」
An impairment loss on investment securities of ¥21 million was recorded in the three-month period of the current consolidated fiscal year, whereas no such loss was recorded in the same period of the previous year. - FY2021No impairment loss on investment securities recognizedAnnual report
「Current consolidated fiscal year (from 1 April 2020 to 31 March 2021) Not applicable.」
No impairment loss was recognized on investment securities in the current fiscal year. - FY2021-Q2RestatedAnnual report
「Impairment loss on investment securities 62 -」
No impairment loss on investment securities was recorded in the six-month period of the current consolidated fiscal year, a decrease from ¥62 million in the same period of the previous year. - FY2021-Q1No impairment loss on investment securities recordedAnnual report
「Impairment loss on investment securities ¥11 million -」
No impairment loss on investment securities was recorded in the three-month period of the current consolidated fiscal year, a decrease from ¥11 million in the same period of the previous year. - FY2020¥63 million impairment loss on investment securities recordedAnnual report
「During the current consolidated fiscal year, an impairment loss of ¥63 million was recognized on shares with market prices classified as other securities.」
The impairment loss on investment securities increased from ¥24 million in total in the previous fiscal year to ¥127 million in total for non-operating expenses and extraordinary losses in the current fiscal year, including ¥63 million in impairment losses on shares with market prices. - FY2020-Q3No impairment loss on investment securities recognizedAnnual report
「Impairment loss on investment securities 61 -」
No impairment loss on investment securities was recorded in the nine-month period of the current consolidated fiscal year, a decrease from ¥61 million in the same period of the previous year. - FY2020-Q2¥62 million impairment loss on investment securities recordedAnnual report
「Impairment loss on investment securities - 62」
An impairment loss on investment securities of ¥62 million was recorded in the six-month period of the current consolidated fiscal year, whereas no such loss was recorded in the same period of the previous year. - FY2020-Q1¥11 million impairment loss on investment securities recordedAnnual report
「Loss on impairment of investment securities - 11」
An impairment loss on investment securities of ¥11 million was recorded in the three-month period of the current consolidated fiscal year, whereas no such loss was recorded in the same period of the previous year. - FY2019Breakdown of impairment loss on investment securities recordedAnnual report
「Loss on impairment of investment securities - 10」
In the current consolidated fiscal year, ¥10 million was recorded as an extraordinary loss, in addition to ¥14 million in impairment losses on investment securities recorded as non-operating expenses. - FY2019-Q3First statedAnnual report
「Loss on valuation of investment securities — 61」
An impairment loss on investment securities of ¥61 million was recorded in the nine-month period of the current consolidated fiscal year, whereas no such loss was recorded in the same period of the previous year.